TCG Labs Soleil Announces $400M Funding Raise

Gunderson Dettmer represented client TCG Labs Soleil, a venture firm integrating capital with an in-house biotech R&D hub, in its new $400 million fundraise. The new funding builds on the firm’s inaugural raise of $400 million in 2024, expanding its ability to efficiently advance single-asset portfolio companies through clinical proof of concept and position them for strategic partnerships.

In the announcement of the funding, TCG Labs Soleil CEO Jin-Long Chen said, “With this new fund and expanded R&D footprint, we’re positioned to advance our portfolio companies through clinical proof of concept and deliver partner-ready programs with greater impact. With several programs heading into the clinic, this additional raise reflects both the pace and productivity we’ve achieved since our inaugural fund, moving programs forward efficiently and opening new opportunities for strategic partnerships.”

The Gunderson deal team was led by Andrew Thornborrow and Chris Partin and included Amanda Chan, Daryl Dietsche and Casey Stevens.

Companies
TCG Labs Soleil